Polaris Venture Partners V L.P. 13D/13G Filings for Lyra Therapeutics, Inc. (LYRA)

Polaris Venture Partners V L.P. 13D and 13G filings for Lyra Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-07
5:05 pm
Unchanged		 2022-12-31 13G Lyra Therapeutics, Inc.
LYRA		 Polaris Venture Partners V L.P. 1,423,772
4.500%		 0
(Unchanged)		 Filing
2021-02-12
5:10 pm
Purchase		 2020-12-31 13G Lyra Therapeutics, Inc.
LYRA		 Polaris Venture Partners V L.P. 1,423,772
11.000%		 1,423,772increase
(New Position)		 Filing